Ardelyx (NASDAQ: ARDX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Hot FDA News Trading Halts

Ardelyx (ARDX) Director Mott Buys $1M in Stock Following Positive FDA PanelNovember 17, 2022 4:14 PM Ardelyx, Inc (ARDX) Stock 'Acting Poorly' Despite 50% Up Move - CitiNovember 17, 2022 1:01 PM FDA AdCom Continues to Discuss Ardelyx's (ARDX) Discuss XPHOZAHNovember 16, 2022 9:02 AM FDA AdCom Continues to Discuss Ardelyx's (ARDX) Discuss XPHOZAHNovember 16, 2022 9:02 AM Ardelyx Stock Trading Halted Today; FDA Advisory Committee to Discuss XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on DialysisNovember 16, 2022 9:00 AM Ardelyx (ARDX) Halted, News Pending Ahead of FDA Panel MeetingNovember 16, 2022 8:56 AM Cowen Weighs in on Ardelyx, Inc (ARDX) FDA Briefing DocumentsNovember 14, 2022 12:36 PM Ardelyx (ARDX) on watch as FDA briefing documents hitNovember 14, 2022 9:28 AM